246
Participants
Start Date
February 28, 2010
Primary Completion Date
August 31, 2016
Study Completion Date
September 30, 2024
BEP(500)
"One cycle of BEP(500):~Etoposide 165 mg/m2 IV infusion - days 1, 2, 3 Cisplatin 50 mg/m2 IV infusion - days 1, 2 Bleomycin 30,000 IU IV infusion - days 1 (or 2), 8, 15"
Guy's Hospital, London
Northampton General Hospital NHS Trust, Northampton
Velindre Cancer Center at Velindre Hospital, Cardiff
Aberdeen Royal Infirmary, Aberdeen
Ysbyty Gwynedd, Bangor
Queen Elizabeth Hospital, Birmingham
Royal Sussex County Hospital, Brighton
Bristol Haematology and Oncology Centre, Bristol
Queen's Hospital, Burton-on-Trent
Addenbrooke's Hospital, Cambridge
Cheltenham General Hospital, Cheltenham
Gloucestershire Royal Hospital, Cheltenham
University Hospitals Coventry and Warwickshire NHS Trust, Coventry
Royal Derby Hospital, Derby
Western General Hospital, Edinburgh
Royal Devon and Exeter Hospital, Exeter
Beatson West of Scotland Cancer Centre, Glasgow
Royal Surrey County Hospital, Guildford
Castle Hill Hospital, Hull
Ipswich Hospital, Ipswich
St James's University Hospital, Leeds
Leicester Royal Infirmary, Leicester
Lincoln County Hospital, Lincoln
Clatterbridge Centre for Oncology, Liverpool
Royal Liverpool University Hospital, Liverpool
St Bartholomew's Hospital, London
University College Hospital, London
Maidstone Hospital, Maidstone
James Cook University Hospital, Middlesbrough
Norfolk and Norwich University Hospital, Norwich
Nottingham City Hospital, Nottingham
Churchill Hospital, Oxford
Weston Park Hospital, Sheffield
Southampton General Hospital, Southampton
Royal Marsden Hospital, Sutton
Collaborators (1)
University Hospital Birmingham NHS Foundation Trust
OTHER
Cancer Research UK
OTHER
Institute of Cancer Research, United Kingdom
OTHER